Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Complementary and Alternative Medicine

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Scientific investigation of crude alkaloids from medicinal plants for the management of pain

  • Mohammad Shoaib1Email author,
  • Syed Wadood Ali Shah1,
  • Niaz Ali2,
  • Ismail Shah1,
  • Shafi Ullah1,
  • Mehreen Ghias1,
  • Muhammad Nawaz Tahir3,
  • Farah Gul4,
  • Sohail Akhtar5,
  • Abd Ullah1,
  • Wajid Akbar1 and
  • Asad Ullah1
BMC Complementary and Alternative MedicineBMC series – open, inclusive and trusted201616:178

https://doi.org/10.1186/s12906-016-1157-2

Received: 18 September 2015

Accepted: 3 June 2016

Published: 13 June 2016

Abstract

Background

Tissue damage is associated with pain, which is an alarming sign. Aspirin and morphine have been widely used in recent decades for management of pain. Medicinal herbs have been in use for treatment of different diseases for centuries. Many of these herbs possess analgesic activity with relatively less incidences of adverse effects. The strong positive correlation of alkaloids in medicinal plants for analgesic activity persuades an intention to determine possible analgesic activity of total alkaloids extracted from the selected medicinal plants using animal models to answer its possible mechanisms.

Methods

Crude alkaloids from selected medicinal plants (Woodfordia fruticosa, Adhatoda vasica, Chenopodium ambrosioides, Vitex negundo, Peganum harmala and Broussonetia papyrifera) were extracted as per reported literature. The test crude alkaloids were screened foracute toxicity study. Writhings induced by acetic acid, tail immersion method and formalin-induced nociception assay procedures were used for possible analgesic effects of the crude alkaloids.

Results

Crude alkaloids were safe up to dose of 1250 mg/kg body weight in mice. The alkaloids significantly reduced the abdominal constrictions, and increased the time for paw licking response in both phases with a significant raise in latency time in nociception models (P ≤ 0.05). Moreover, the antinociceptive response was significantly attenuated by pretreatment with naloxone suggesting involvement of the opioid receptors for possible antinociceptive action.

Conclusions

Crude alkaloids of Woodfordia fruticosa and Peganum harmala showed prominent analgesic potentials through inhibition of peripheral as well as central nervous system mechanisms. Further work is required for isolation of the pharmacologically active constituents.

Keywords

Crude alkaloids Woodfordia fruticosa Peganum harmala Traditional usesPainNaloxoneOpioid

Background

International Association for the Study of Pain (IASP) defines pain as “a disagreeable sensory and arousing experience coupled by real or potential tissue damage” [1]. Usually pain is thought to be an alarming sign of actual or apparent tissue damagethat warns the subject for possible unwanted outcome. Therefore,the subject seeks averting reaction for possible defense [2]. Aspirin and morphine are in use for analgesic purposes in recent decades. Opioids and nonsteroidal anti-inflammatory drugs (NSAIDs) have been reported to relieve pain sometimes by 50 % in 30 % of recipients [3]. The uses of these analgesics are associated with incidences of adverse effects like opiates cause physical dependence, tolerance and addiction. NSAIDs are frequently associated with gastrointestinal disorders like gastric or duodenal ulceration [4].

This necessitates for discovery of relatively safe alternatives for treatment of pain. Medicinal herbs have been used for therapeutic purposesfor centuries. Many of these herbs had been used for pain management without any evident adverse effects [5]. Ethno-pharmacologically guided research has brought considerable contributions to new drug development [6, 7]. There has been an increasing interest to find new and safe anti-inflammatory and analgesic drugs from natural sources including medicinal plants [8]. Medicinal plants have been very useful source for lead structure for subsequent synthetic modification and optimization of bioactivity.

Alkaloids are naturally occurring active diverse group of secondary metabolites in plants that has been used in medicine for hundreds years [9].

Plants like Woodfordia fruticosa, Adhatoda vasica, Chenopodium ambrosioides, Viburnum cotinifolium, Vitex negundo, Peganum harmala and Broussonetia papyrifera have been investigated scientifically for presence of alkaloids with reference to their ethno pharmacological profile in pain management [10, 1116].

Analgesic activity of alkaloids isolated from plants is reported with different mechanistic approaches [1720]. The strong positive correlation of alkaloids in medicinal plants for analgesic activity persuades an intention to determine possible analgesic activity of total alkaloids extracted from the mentioned medicinal plants using animals’ model.

Methods

Plant materials

The collected plant species namely Woodfordia fruticosa (voucher specimen Wf-01-2015, Lythraceae, Swat, aerial parts), Adhatoda vasica syn. Justicia adhatoda (voucher specimen Av-02-2015, Acanthaceae, Kohat, leaves), Chenopodium ambrosioides (voucher specimen Ca-03-2015, Chenopodiaceae, Peshawar, leaves), Vitex negundo (voucher specimen Vn-04-2015, Verbenaceae, Swat, aerial parts), Peganum harmala (voucher specimen Ph-05-2015, Zygophyllaceae, Peshawar, aerial parts) and Broussonetia papyrifera syn. Morus papyrifera (voucher specimen Bp-06-2015, Moraceae, Dir Lower, aerial parts) were identified by Dr. Jehandar Shah, ex Vice Chancellor, University of Malakand. The materials were dried under shade. Respective voucher specimens were submitted to the herbarium of Department of Botany, University of Malakand, Dir Lower, Khyber Pakhtunkhwa.

Extraction of crude alkaloids

The crude alkaloidal extracts from the plants were obtained according to the method of Harborne with slight modifications. Briefly, dried powdered plants materials (100 g) were defatted using Soxhlet apparatus (Quickfit, UK) followed by an extraction process with 10 % acetic acid (200 ml) in ethanol for 24 h in Soxhlet apparatus. The extract was concentrated using rotary evaporator till a concentrated mass. The pH was adjusted to 9 by the addition of concentrated ammonium hydroxide solution. It was then extracted with chloroform (50 ml) three times. During extraction, the contents were subjected to vigorous shaking. The chloroform layer was separated using separating funnel. The chloroform portion was concentrated using rotary evaporator. Presence of alkaloids was confirmed with Dragendorff’s, Mayer’s or picric acid reagent. The alkaloids were stored in a clean amber glass vial at 4 °C. Similar procedure was used to extract crude alkaloids from the aforementioned specimens. The alkaloids were successively labeled as Woodfordia fruticosa crude alkaloid (Wf Cr.A), Adhatoda vasica crude alkaloid (Av Cr.A), Chenopodium ambrosioides crude alkaloid (Ca Cr.A), Vitex negundo crude alkaloid (Vn Cr.A), Peganum harmala crude alkaloid (Ph Cr.A) and Broussonetia papyrifera crude alkaloid (Bp Cr.A) [2123].

Drugs and standards

Analytical grade chemicals were used in the experiments. Acetylcholine was purchased from BDH, Poole, England. Other chemicals were of E. Merck grade. All the stock solutions were prepared in distilled water. Fresh dilutions were made in normal saline.

Animals

Either sex Balb/C mice (weight range: 25-30 g) were purchased from National Institute of Health Islamabad. They were housed in the animal house of the University of Malakand, Pakistan under a controlled environment (23-25 °C). The animals were fasted overnight before the start of the experiments. They were treated as per the principles mentioned in the “Animals Byelaws 2008 of University of Malakand (Scientific Procedures Issue-I)”. Ethical Committee of the Department of Pharmacy, constituted under the approved Animals Byelaws 2008 of University of Malakand, endorsed the study protocols.

Acute toxicity

Acute toxicity study for crude alkaloids was carried out as per procedure reported by Lorke [24]. Male mice were selected by random sampling technique and three groups for individual test sample for two phases were used for the determination of LD50. In the initial phase, the mice were orally treated with 125, 250 and 500 mg/kg of the alkaloidal extract. All test samples were tested in similar manner. The groups were observed for possible mortality in 24 h. In the second phase, the mice were treated with the test alkaloids extract in doses of 750, 1000 and 1250 mg/kg. Death toll was noted in 24 h. LD50was calculated [24, 25].

Acetic acid-induced writhing

Analgesic activity was carried out in mice. Writhings were induced using acetic acid. Briefly, Balb/ C male mice were divided into different groups having six animals in each group. The animals were pretreated with crude alkaloids of various medicinal plants at a dose of 50 mg/kg (i.p.). Diclofenac sodium (50 mg/kg, i.p.) was used as standard analgesic agent. The test samples and standard drugs were administered 1 h before of intraperitoneal injection of 1 % (v/v) acetic acid (0.1 ml/10 g). Five minutes after the injection (i.p) of acetic acid, counted the number of writhing following 10 min. Negative control group received carboxy methyl cellulose (CMC) 0.5 % and vehicle only [26].

Formalin test

This test was performed by the method of assessing the licking response of formalin-induced edema in paw of mice. 20 μl of 1 % formalin prepared in 0.9 % saline was administered (s.c) to the dorsal hind paw and immediately placed in the transparent box for observing the licking response. The duration of reaction time (paw licking or biting) was determined between 0 and 5 min (first phase) and 15–30 min (second phase). Animals in different groups were treated test samples (50 mg/kg, i.p), indomethacin (10 mg/kg, i.p) and morphine (5 mg/kg, i.p), 30 min prior to administration of formalin. Naloxone (2 mg/kg, i.p) was administered 20 min prior to treatment of animals with test samples and standards. Control animals received the vehicle (0.1 ml/10 g). The reaction time of the animals in respective groups was compared to control group and expressed as percent inhibition [27].

Tail immersion method

The animals were divided into groups of six animals each. To prelabelled group (CMC 0.5 %), morphine (5 mg/kg), and crude alkaloids at a dose of 50 mg/kg of different medicinal plants were given. Time for tail withdrawal from the water was measured before and after drug treatment in a regular interval of 15, 30, 45, 60, 75 and 90 min by immersing the tail tips (1-2 cm) of the mice in water bath thermostatically maintained at temperature of 55 ± 1 °C with a cut-off time of immersion at 10 s. The actual flick response of mice was measured by stop watch and results were compared with control and standard group [27].

Statistical analysis

Data are presented as mean ± SEM. Analysis of variance and Dunnett’s test is statistically manipulated with GraphPad prism software version 5.01.

Results

After 24 h of observation, in acute toxicity test, no behavioral and physical changes in mice were observed at doses below 1250 mg/kgbody weight for crude alkaloids.

The effect of crude alkaloids in the acetic acid induced writhing model is mentioned in Fig. 1. The compounds antagonized abdominal constrictions at a dose of 50 mg/kg i.p., maximum pain alleviation (78.45 %, P < 0.001, n = 6) was observed for Woodfordia fruticosa crude alkaloid followed by Peganum harmala crude alkaloid (72.13 %, P < 0.001, n = 6). Other alkaloids also produce protection against acetic acid to 63.50, 61.99, 51.10 and 43.03 respectively for Broussonetia papyrifera crude alkaloid, Adhatoda vasica crude alkaloid, Vitex negundo crude alkaloid and Chenopodium ambrosioides crude alkaloid. The standard diclofenac sodium produce significant protection of 86.42 %, P < 0.001, n = 6 at a dose of 50 mg/kg i.p.
Fig. 1

Analgesic activity of crude alkaloids using acetic acid induced writhing model. All the values are expressed as mean ± SEM (n = 6). * P < 0.05, ** P < 0.01, *** P < 0.001 when compared to control group

The results of the crude alkaloids in post formalin induced flinching behavior are presented in Table 1 and Fig. 2. The compounds produced significant reduction in noxious stimulation in both phases. Pretreatment of test samples at the dose of 50 mg/kg i.p. showed marked attenuation of noxious stimulation in both phases in which Woodfordia fruticosa crude alkaloid (Wf Cr.A) was dominant with 72.37 and 54.22 % in the both phases, respectively. Similar tendency was produced by Peganum harmala crude alkaloid (Ph Cr.A) with 66.31 and 49.16 % control in the 1st and 2nd phases respectively (Fig. 2a and b). The other crude alkaloids also produced moderate to good reduction in noxious stimulation in both phases. The standard indomethacin at a dose of 10 mg/kg produced significant effects of 74.37 % in second phase while less effects were produced in first phase. The centrally acting standard morphine at a dose of 5 mg/kg significantly reduced the noxious stimulation in both phases upto 96.11 % (P < 0.001, n = 6) and 86.86 % (P < 0.001, n = 6) respectively.
Table 1

Effects of crude alkaloids and standardson formalin-induced paw-licking response in mice

Treatment/Dose

Licking time (Sec)

Inhibition (%)

1st Phase

2nd Phase

1st Phase

2nd Phase

Control (2 % Tween 80)

48.83 ± 1.627

72.83 ± 1.287

----

----

Wf Cr.A 50 mg

22.35 ± 1.231***

20.12 ± 1.163***

54.22

72.37

Av Cr.A 50 mg

28.31 ± 1.347**

31.45 ± 1.342***

42.14

56.81

Ca Cr.A 50 mg

34.75 ± 1.441*

44.39 ± 1.568*

28.68

39.04

Vn Cr.A 50 mg

33.35 ± 1.604*

38.93 ± 1.195**

31.82

46.54

Ph Cr.A 50 mg

24.85 ± 1.289***

24.53 ± 1.391***

49.16

66.31

Bp Cr.A 50 mg

27.80 ± 1.468**

33.79 ± 1.416**

43.09

53.60

Indomethacin (10 mg)

39.83 ± 1.541

18.66 ± 1.542***

18.43

74.37

Morphine (5 mg)

6.416 ± 1.165***

2.83 ± 1.260***

86.86

96.11

All the values are expressed as mean ± SEM. * P < 0.05, ** P < 0.01 and *** P < 0.001 when compared to control group (one way ANOVA followed by Dunnetts: compare all vs control test)

Fig. 2

a Analgesic effect of extracted crude alkaloids on formalin induced licking response in first phase of the test. Values are mean ± SEM, n = 6, * P < 0.05, ** P < 0.01, *** P < 0.001 significantly different compared with control. b: Analgesic effect of extracted crude alkaloids on formalin induced licking response in second phase of the test. Values are mean ± SEM, n = 6, * P < 0.05, ** P < 0.01, *** P < 0.001 significantly different compared with control

In thermal nociception model, the tail immersion test has been carried out for finding the central effect of crude alkaloids. In this test, Woodfordia fruticosa crude alkaloid at 50 mg/kg (i.p) showed its highest analgesic response at all time points (15-90 min) in comparison with alkaloids of other plants. The results of these crude alkaloids are shown in Table 2. Morphine was used as reference at a dose of 5 mg/kg, i.p.
Table 2

Analgesic effects of crude alkaloids and standard drugs using tail flick method

 

Time in Sec (Tail Flick)/Response (%)

Treatment/Dose

15 min

30 min

45 min

60 min

75 min

90 min

Control (2 % Tween 80)

0.78 ± 1.30

0.88 ± 1.21

0.98 ± 1.021

0.93 ± 1.381

0.86 ± 1.025

0.92 ± 1.401

Wf Cr.A 50 mg

1.01 ± 1.12* (22.70 %)

1.38 ± 1.112* (36.23 %)

1.68 ± 1.131** (41.66 %)

2.13 ± 1.124** (56.33 %)

2.41 ± 1.163*** (64.31 %)

2.15 ± 1.138*** (57.20 %)

Av Cr.A 50 mg

0.92 ± 1.20 (15.21 %)

1.14 ± 1.411* (22.52 %)

1.41 ± 1.161** (30.49 %)

1.48 ± 1.201** (37.16 %)

1.65 ± 1.206*** (47.87 %)

1.57 ± 1.282*** (41.40 %)

Ca Cr.A 50 mg

0.89 ± 1.30 (12.35 %)

1.09 ± 1.411* (19.85 %)

1.35 ± 1.161** (27.40 %)

1.39 ± 1.231** (33.09 %)

1.53 ± 1.226*** (43.79 %)

1.49 ± 1.218*** (38.25 %)

Vn Cr.A 50 mg

0.90 ± 1.10 (13.81 %)

1.12 ± 1.521* (21.75 %)

1.38 ± 1.611** (28.98 %)

1.40 ± 1.421** (33.80 %)

1.55 ± 1.261*** (44.69 %)

1.51 ± 1.618*** (39.27 %)

Ph Cr.A 50 mg

0.97 ± 0.82 (19.58 %)*

1.23 ± 1.135* (28.45 %)

1.70 ± 1.141** (42.35 %)

2.08 ± 1.511** (55.28 %)

2.33 ± 1.133** (63.09 %)

2.04 ± 1.123** (54.90 %)

Bp Cr.A 50 mg

0.90 ± 0.97 (13.81 %)

1.11 ± 1.411* (20.42 %)

1.37 ± 1.261** (28.46 %)

1.42 ± 1.301** (34.50 %)

1.57 ± 1.237*** (45.22 %)

1.53 ± 1.218*** (39.90 %)

Standard (Morphine 5 mg)

1.54 ± 1.24** (49.35 %)

2.11 ± 1.066** (58.29 %)

4.52 ± 1.038*** (78.31 %)

6.12 ± 1.054*** (84.80 %)

4.98 ± 1.309*** (82.70 %)

4.74 ± 1.074*** (80.59 %)

Wf Cr.A (50 mg) + Naloxone (2 mg)

0.82 ± 0.83

0.81 ± 1.165

0.93 ± 1.049

0.99 ± 1.308

0.87 ± 1.029

0.83 ± 1.461

Av Cr.A (50 mg) + Naloxone (2 mg)

0.96 ± 0.91

0.86 ± 1.036

0.88 ± 1.131

0.94 ± 1.047

0.89 ± 1.381

0.84 ± 1.069

Ca Cr.A (50 mg) + Naloxone (2 mg)

0.84 ± 1.08

0.91 ± 1.044

0.84 ± 1.045

0.89 ± 1.642

0.94 ± 1.263

0.78 ± 1.422

Vn Cr.A (50 mg) + Naloxone (2 mg)

0.94 ± 1.03

0.88 ± 1.051

0.81 ± 1.521

0.83 ± 1.342

0.86 ± 1.061

0.87 ± 1.356

Ph Cr.A (50 mg) + Naloxone (2 mg)

0.81 ± 0.69

0.96 ± 1.031

1.05 ± 1.271

0.97 ± 1.535

0.91 ± 1.251

0.93 ± 1.034

Bp Cr.A 50 mg + Naloxone (2 mg)

0.88 ± 1.124

0.81 ± 0.89

0.94 ± 1.034

0.86 ± 1.324

0.93 ± 1.304

0.94 ± 1.263

Morphine (5 mg) + Naloxone (2 mg)

0.76 ± 0.82

0.87 ± 1.336

0.96 ± 1.204

0.95 ± 1.641

0.89 ± 1.035

0.97 ± 1.432

All the values were expressed as mean ± SEM. * P < 0.05, ** P < 0.01 and *** P < 0.001 when compared to control group (one way ANOVA followed by Dunnetts: compare all vs control test)

The analgesic response of alkaloids was significantly antagonized by naloxone at all the time intervals. The crude alkaloids extracted from different medicinal plants exhibited good to significant analgesic effect in tail immersion test, indicating the involvement of both spinal and supraspinal analgesic pathways.

Upon the administration of the nonselective opioid receptor antagonist naloxone, the analgesic response of crude alkaloids was antagonized.

Discussions

Plants have been in continuous use for treatment of various ailments since creature of human beings. Today many of the current drugs are from natural sources [28]. Pain management sometimes requires more than one drug therapy. Thus the practice of polypharmacy carries risks of adverse drug reactions and or side effects. Therefore, search for new drugs with the same therapeutic efficacy with relatively less frequency of side effects is the need of the time [29, 30].

This study helped us in understanding the possible mechanisms of potential analgesic effect of the test alkaloids that work through inhibition of central nervous system and peripheral nervous system. The abdominal constriction induced by acetic acid is thought to be due to the involvement of peripheral mechanisms, while tail immersion test is thought to be due to central mechanisms [31]. Formalin test is used for both peripheral and central mechanisms [32].

Acetic acid-induced writhing is a well-recommended model to assess the analgesic proprieties of drugs having analgesic and anti-inflammatory activity. Acetic acid performs its action by release of endogenous mediators like prostaglandins from arachidonic acid through cyclooxygenase enzymes. These prostaglandins stimulate the nociceptive neurons [33, 34] with induction of pain sensation. The abdominal constriction response may also be due to the activation of local peritoneal receptors [35] and involved prostanoids mediators.

NSAIDs possess analgesic activity by inhibiting the cyclooxygenase pathway and synthesis of the prostaglandins that confirm the involvement of peripheral mechanism in inhibition of pain [36]. Thus NSAIDs in writhing model are used as positive control for inhibition of pain that works through peripheral mechanism [37, 38]. Therefore, the analgesic action of crude alkaloids seems to be due to inhibition of cyclooxygenase or 5-lipoxygense pathways that may be attributed to inhibition of inflammatory cytokines and interleukins [39].

The formalin test model is used to investigate on the ability to exert peripheral and or central analgesic effects as it assays biphasic characteristics, labeled as the early and late phases that occur as a result of formalin administration [40]. The early phase is a neurogenic pain resulting from an acute response towards direct action of formalin on nociceptors within the intraplantar region, while the late phase is considered as an inflammatory-mediated pain resulting from a tonic response due to the release of inflammatory mediators [41]. There may be activation of the neurons in the dorsal horns of the spinal cord as well [42, 43]. Generally, the peripherally-acting drugs like aspirin blocks the synthesis of prostaglandins,which inhibit the late phase only, while narcotic analgesics (centrally-acting) inhibit nociception in both phases of the formalin test [44, 45].

Tail immersion test is selective for morphine like compounds. It tests the reflex responses involved through the spinal cord for possible sensation of nociceptive stimuli [46]. The brain and spinal cord play an important role in central pain mechanism. Dorsal part of spinal cord is rich withsubstance P, endogenous opioids, somatostatin, and other inhibitory hormones which are the targets of pain and inflammation [47]. The results of the tail immersion test indicated that antinociceptive effect of crude alkaloids and standard morphine was reversed by naloxone suggests the involvement of opioid receptors at level of spinal cord. It has been suggested that μ2- and δ- opioid receptors are involved in spinal mechanism [48]. Therefore, it can be anticipated that the central analgesic effects of extracted crude alkaloids may be prominent on μ-opioid receptors.

The crude alkaloidal extractsof different medicinal plants possess analgesic potentials possibly through inhibion of central and peripheral pain mediators. The antinociceptive activity confirms traditional uses of the aforementioned medicinal plants for the management of pain.

Conclusion

Crude alkaloids of Woodfordia fruticosa and Peganum harmala showed prominent analgesic potentials that requires further work for isolation of pharmacologically active constituents.

Abbreviations

Av Cr.A, Adhatoda vasica crude alkaloid; Bp Cr.A, Broussonetia papyrifera crude alkaloid; Ca Cr.A, Chenopodium ambrosioides crude alkaloid; CMC, Carboxy methyl cellulose; Ph Cr.A, Peganum harmala crude alkaloid; s.c, subcutaneous; Vn Cr.A, Vitex negundo crude alkaloid; Wf Cr.A, Woodfordia fruticosa crude alkaloid.

Declarations

Acknowledgements

The authors are thankful to University of Malakand Chakdara Dir Lower KPK, and International Center for Chemical and Biological Sciences (ICCBS, HEJ), Karachi, Pakistan for providing the facilities.

Funding source

No fund was provided by any funding agency for this study.

Availability of data and materials

The data sets supporting the conclusions of this article are presented in this main paper. Plant materials used in this study have been identified at the University of Malakand and voucher specimens are deposited Herbarium of Botanical garden.

Authors’ contributions

MS: Supervision of whole project. SWAS: Extraction of alkaloids. NA: Supervision of the pharmacological tests and manuscript preparation.IS: Collaborated in manuscript preparation. S: Performed the pharmacological tests. MG: Performed the pharmacological tests. MNT: Interpret the data. SA: Collaborated in statistical interpretation. A, WA, AU: Performed the pharmacological tests. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not relevant.

Ethics approval and consent to participate

Standard experimental protocols were followed as per the guidelines of ethical committee of Department of Pharmacy, University of Malakand as per Bye Laws 2008 of the University of Malakand (Scientific Procedures Issue-I).

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Pharmacy, University of Malakand
(2)
Department of Pharmacology, Institute of Basic Medical Sciences, Khyber Medical University
(3)
Department of Physics, University of Sargodha
(4)
Pharmacology Section, PCSIR Laboratories Complex
(5)
Department of Statistics, University of Malakand

References

  1. Merskey H. Pain terms: a list with definitions and notes on usage. Recommended by the lASP subcommittee on Taxonomy. Pain. 1979;6:249–52.View ArticleGoogle Scholar
  2. Unruh A, Strong J, Wright A. Introduction. In: Strong J, Unruh AM, Wright A, Baxter GD, Wall PD, editors. Pain: a textbook for therapists. London: Churchill Livingstone; 2002.Google Scholar
  3. Hewitt DJ, Hargreaves RJ, Curtis SP, Michelson D. Challenges in analgesic drug development. Clin Pharmacol Ther. 2009;86:447–50.PubMedGoogle Scholar
  4. Hanson GR, Venturelli PJ, Fleckenstein AE. Drugs and society. 10th ed. Boston, Mass: Jones and Bartlett; 2011.Google Scholar
  5. Fan SH, Noraisah AA, Dayang FB. Evaluation of analgesic activity of the methanol extract from the galls of Quercus infectoria (Olivier) in rats. J Evid Based Complementary Altern Med. 2014;2014:1–6.View ArticleGoogle Scholar
  6. Rates SMK. Plants as source of drugs. Toxicon. 2001;29:603–13.View ArticleGoogle Scholar
  7. Zainul AZ, Hijaz MS, Manraj SC, Arifah AK, Teh LK, Mohd ZS. Antinociceptive activity of methanolic extract of Muntingia calabura leaves: further elucidation of the possible mechanisms. BMC Complement Altern Med. 2014;14:63–75.View ArticleGoogle Scholar
  8. Asie S, Majid M, Sima N, Manijeh M. Evaluation of anti-inflammatory and analgesic activity of the extract and fractions of Astragalus hamosus in animal models. Iran J Pharm Res. 2015;14:263–9.Google Scholar
  9. Roberts MF, Wink M. Introduction. In: Roberts MF, Wink M, editors. Alkaloids: biochemistry, ecology, and medicinal applications. Springer Street, New York: Plenum Press; 1998.View ArticleGoogle Scholar
  10. Amir MK, Rizwana AQ, Faizan U, Syed AG, Asia N, Sumaira S, Muhammad KL, Muhammad YL, Shafiq UR, Ishtiaq H, Waheed M. Phytochemical analysis of selected medicinal plants of Margalla hills and surroundings. J Med Plants Res. 2011;5:6017–23.Google Scholar
  11. Yogesh B, YV, Sumitra C. Brine shrimp cytotoxicity, anti-inflammatory and analgesic properties of Woodfordia fruticosa Kurz flowers. Iran J Pharm Res. 2012; 11: 851-861.Google Scholar
  12. Wahid AM, Suyog DM, Suraj BJ, Ajinkya MP, Mukhtar SK, Madhukar RV. Evaluation of antiinflammatory and analgesic activities of ethanolic extract of roots Adhatoda vasica Linn. Int J PharmTech Res. 2010;2:1364–8.Google Scholar
  13. Ibironke GF, Ajiboye KI. Studies on the anti-inflammatory and analgesic properties of Chenopodium ambrosioides leaf extract in rats. Int J Pharm. 2007;3:111–5.View ArticleGoogle Scholar
  14. Zhenga CJ, Tangb WZ, Huanga BK, Hana T, Zhanga QY, Zhanga H, Qin LP. Bioactivity-guided fractionation for analgesic properties and constituents of Vitex negundo L. seeds. Phytomedicine. 2009;16:560–7.View ArticleGoogle Scholar
  15. Loubna F, Amine L, Rachida A, Ahmed B, Abderrahman C. Evaluation of the analgesic effect of alkaloid extract of Peganum harmala L. Possible mechanisms involved. J Ethnopharmacol. 2008;115:449–54.View ArticleGoogle Scholar
  16. Lin LW, Chen HY, Wu CR, Liao PM, Lin YT, Hsieh MT, Ching H. Comparison with various parts of Broussonetia papyrifera as to the antinociceptive and anti-inflammatory activities in rodents. Biosci Biotechnol Biochem. 2008;72:2377–84.PubMedGoogle Scholar
  17. Irene MV, Arlyn CS. Cassiaindoline, a new analgesic and anti-inflammatory alkaloid from Cassia alata. Z Naturforsch C. 2009;64:335–8.Google Scholar
  18. Kaleem WA, Muhammad N, Qayum M, Khan H, Khan A, Aliberti L, Vincenzo DF. Antinociceptive activity of cyclopeptide alkaloids isolated from Ziziphus oxyphylla Edgew (Rhamnaceae). Fitoterapia. 2013;91:154–8.View ArticlePubMedGoogle Scholar
  19. Fagner CL, Jaime RF, Hermann FC, Paula RRS, Andrea SC, Alan BC, de Almeida RN, Dias Cda S, Bozza PT, Piuvezam MR. Curine, an alkaloid isolated from Chondrodendron platyphyllum inhibits prostaglandin E2 in experimental models of inflammation and pain. Planta Med. 2014;80:1072–8.Google Scholar
  20. Muhammad N, Shrestha RL, Adhikari A, Wadood A, Khan H, Khan AZ, Maione F, Mascolo N, De Feo V. First evidence of the analgesic activity of govaniadine, an alkaloid isolated from Corydalis govaniana Wall. Nat Prod Res. 2014;29:430–7.Google Scholar
  21. Harborne JB. Phytochemical methods. 2nd ed. New York: Chapman and Hall; 1984.View ArticleGoogle Scholar
  22. Mahboba BN, Rabia OA, Nabil AS, Asma YAN. Evaluation of antibacterial and antioxidant activities of Artemisia campestris (Astraceae) and Ziziphus lotus (Rhamnacea). Arab J Chem. 2010;3:79–84.View ArticleGoogle Scholar
  23. Shammary AAH, Malik AASS, Saeidy MAA. Evaluation of analgesic activity and toxicity of alkaloids in Myristica fragrans seeds in mice. J Pain Res. 2013;6:611–5.Google Scholar
  24. Lorke D. A New approach to practical acute toxicity testing. Arch Toxicol. 1983;53:275–87.View ArticleGoogle Scholar
  25. Niaz A, Hina A, Aslam K, Ghayour A, Wadood AS, Muhammad N, Muhammad J. Antispasmodic and antidiarrhoeal activity of the fruit of Rosa moschata (J). BMC Complement Altern Med. 2014;14:485–90.View ArticleGoogle Scholar
  26. Koster R, Anderson M, Beer EJ. Acetic acid for analgesic screening. Fed Proc. 1959;18:412–8.Google Scholar
  27. Pandurangan SB, Paul AS, Savarimuthu I, Ali AA. Antinociceptive, immunomodulatory and antipyretic activity of nymphayol isolated from Nymphaea stellata (Willd.) flowers. Biomol Ther. 2013;21:391-97.Google Scholar
  28. Bonito MC, Cicala C, Marcotullio MC, Maione F, Mascolo N. Biological activity of bicyclic and tricyclic diterpenoids from Salvia species of immediate pharmacological and pharmaceutical interest. Nat Prod Commun. 2011;8:1205–15.Google Scholar
  29. Alfieri A, Maione F, Bisio A, Romussi G, Mascolo N, Cicala C. Effect of a diterpenoid from Salvia cinnabarina on arterial blood pressure in rats. Phytother Res. 2007;7:690–2.View ArticleGoogle Scholar
  30. Maione F, Cicala C, Musciacco G, De Feo V, Amat AG, Ialenti A, Mascolo N. Phenols, alkaloids and terpenes from medicinal plants with antihypertensive and vasorelaxant activities: a review of natural products as leads to potential therapeutic agents. Nat Prod Commun. 2013;4:539–44.Google Scholar
  31. Paulino N, Dantas AP, Bankova V, Longhi DT, Scremin A, Decastro SL, et al. Bulgarian propolis induces analgesics and antiinflammatory effects in mice and inhibits in-vitro contraction of airway smooth muscle. J Pharmacol Sci. 2003;93:307–13.View ArticlePubMedGoogle Scholar
  32. Tjolsen A, Berge OG, Hunskaar S, Rosland JH, Hole K. The formalin test: an evaluation of the method. Pain. 1992;51:5–17.View ArticlePubMedGoogle Scholar
  33. Collier HO, Dinneen LC, Johnson CA, Schneider C. The abdominal constriction response and its suppression by analgesic drugs in the Mouse. Br J Pharmacol Chemother. 1968;32:295–310.View ArticlePubMedPubMed CentralGoogle Scholar
  34. Dhara AK, Suba V, Sen T, Pal S, Nagchaudhuri AK. Preliminary studies on the anti-inflammatory and analgesic activity of the methanolic fraction of the root extract of Tragia involucrate. J Ethnopharmacol. 2000;72:265–8.View ArticlePubMedGoogle Scholar
  35. Bentley GA, Newton SH, Starr J. Studies on the anti-nociceptive action of a agonist drugs and their interaction with opioid mechanisms. Br J Pharmacol. 1983;79:125–34.View ArticlePubMedPubMed CentralGoogle Scholar
  36. Duarte I, Nakamura M, Ferreira S. Participation of the sympathetic system in acetic acid-induced writhing in mice. Braz J Med Biol Res. 1988;21:341–3.PubMedGoogle Scholar
  37. Vane JR, Botting RM. The mechanism of action of aspirin. Thromb Res Rev. 2003;110:255–8.View ArticleGoogle Scholar
  38. Biswal S, Das MC, Nayak P. Antinociceptive activity of seeds of Trigonella foenumgraecum in rats. Indian J Physiol Pharmacol. 2003;47:479–80.PubMedGoogle Scholar
  39. Reibero RA, Vale ML, Thomazzi SM, Pascholato ABP, Poole S, Ferreira SH, et al. Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice. Eur J Pharmacol. 2000;387:111–8.View ArticleGoogle Scholar
  40. Malmberg AB, Yaksh TL. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharm Exp Ther. 1992;263:136–46.Google Scholar
  41. Verma PR, Joharapurkar AA, Chatpalliwar VA, Asnani AJ. Antinociceptive activity of alcoholic extract of Hemidesmus indicus R.Br. in mice. J Ethnopharmacol. 2005;102:298–301.View ArticlePubMedGoogle Scholar
  42. Hunskaar S, Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain. 1987;30:103–14.View ArticlePubMedGoogle Scholar
  43. Tang L, Chen Y, Chen Z, Blumberg PM, Kozikowski AP, Wang ZJ. Antinociceptive pharmacology of N-(4-chlorobenzyl)-N’-(4-hydroxy-3-iodo-5-methoxybenzyl) thiourea, a high-affinity competitive antagonist of the transient receptor potential vanilloid 1 receptor. J Pharm Exp Ther. 2007;321:791–8.View ArticleGoogle Scholar
  44. Shibata M, Ohkubo T, Takahashi H, Inoki R. Modified formalin test: characteristic biphasic pain response. Pain. 1989;38:347–52.View ArticlePubMedGoogle Scholar
  45. Mohammad I, Mohamad Y, Mohammad ZS, Teh LK, Norizan A, Nik FNA, et al. Activity-guided isolation of bioactive constituents with antinociceptive activity from Muntingia calabura L. Leaves using the formalin test. Evid Based Complement Alternat Med. 2013;2013:1–9.Google Scholar
  46. Manju B, Jagtap AG. Exploring the possible mechanisms of action behind the antinociceptive activity of Bacopa monniera. Int J Ayurveda Res. 2011;2:2–7.View ArticleGoogle Scholar
  47. Curdy CRM, Scully SS. Analgesic substances derived from natural products (natureceuticals). Life Sci. 2005;78:476–84.View ArticleGoogle Scholar
  48. Jinsmaa Y, Okada Y, Tsuda Y, Sasak Y, Ambo A, Bryant SD, et al. Novel 2′,6′ dimethyl-l-tyrosine-containing pyrazinone opioid mimetic A agonists with potent antinociceptive activity in mice. J Pharmacol Exp Ther. 2004;309:1–7.Google Scholar

Copyright

© The Author(s). 2016

Advertisement